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Porous vaterite CaCO3 crystals are widely used as containers for drug loading and as sacrificial templates
to assemble polymer-based nano- and micro-particles at mild conditions. Special attention is paid
nowadays to mucosal delivery where the glycoprotein mucin plays a crucial role as a main component
of a mucous. In this work mucoadhesive properties of vaterite crystals have been tested by investigation
of mucin binding to the crystals as a function of (i) time, (ii) glycoprotein concentration, (iii) adsorption
conditions and (iv) degree of mucin desialization. Mucin adsorption follows Bangham equation indicating
that diffusion into crystal pores is the rate-limiting step. Mucin strongly binds to the crystals
(DG = 35 ± 4 kJ mol1) via electrostatic and hydrophobic interactions forming a gel and thus giving
the tremendous mucin mass content in the crystals of up to 16%. Despite strong intermolecular
mucin-mucin interactions, pure mucin spheres formed after crystal dissolution are unstable. However,
introduction of protamine, actively used for mucosal delivery, makes the spheres stable via additional
electrostatic bonding. The results of this work indicate that the vaterite crystals are extremely promising
carriers for mucosal drug delivery and for development of test-systems for the analysis of the
mucoadhesion.
 2019 The Authors. Published by Elsevier Inc. This is anopenaccess article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).m-Golm,
a@izi-bb.
Fig. 1. Schematic structure of mucin glycoproteins.
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Biodegradable and biocompatible CaCO3 crystals are actively
used as the templates for the preparation of polymer particles for
various applications [1–4] and also directly utilized as containers
for loading of biologically active substances (BAS) of various nature
[5–9]. Among all the polymorphs of CaCO3, special attention is paid
to the vaterite crystals [4]. Conventionally, simple methods are
employed for the fabrication of the vaterite crystals. These crystals
are microspheres of the size that can vary from hundreds of
nanometers up to tens of micrometers. The main advantage of
the crystals is a highly porous internal structure offering a large
surface. The change of the size of nanocrystallines that formmicro-
crystals can be controlled via variation of crystal preparation con-
ditions that leads to a change in the pore size and the adsorption
capacity of macromolecules with different molecular weights
[10]. The inclusion of both high-molecular-weight biomolecules
(enzymes, proteins, hormones, DNA, RNA) and low-molecular-
weight soluble and insoluble substances (antibiotics, anti-cancer
agents, etc.) has been reported [4,5,11–22]. Varying the composi-
tion of preparation medium and using various biopolymers or
lipids as additives gives an option to suppress the recrystallization
of the vaterite crystals into thermodynamically more stable modi-
fications and thus regulate the release of BAS [20,23–25]. Different
approaches for the employment of nano- and micro-sized vaterite
crystals for delivery of various BASs have been discussed [21],
including mucosal delivery through mucosal surfaces [8,26].
Mucoadhesive drugdelivery systems [27,28] includebuccal, oral,
vaginal, rectal, nasal and ocular delivery systems [29–32]. Mucous
surfaces of various organs differ in their structure, thickness and
composition [28]. Mucins are essential andmost important compo-
nent of mucus which mainly determines the transit and protective
properties ofmucous surfaces [33–35].Mucinsare broadly classified
as two types - secreted mucins and membrane bound mucins.
Mucins are extracellular glycoproteins of large molecular
weights of 0.5–20 MDa. Both membrane bound mucins, and
secreted mucins [36] share many common features. They
consist of ca 80% of carbohydrates which are mainly N-
acetylgalactosamine, N-acetylglucosamine, fucose, galactose, and
N-acetylneuraminic (sialic) acid. These carbohydrates are oligosac-
charide chains consisting of 5–15 monomers. Oligosaccharides are
attached to the protein core via covalent O-glycosidic bonds with
the side hydroxyl groups of serine and threonine. This structure
ensures so called bottle-brush configuration about the protein core.
Remaining up to 20% of the molecular mass of mucin consists of the
protein core that is arranged into two distinct regions. A central gly-
cosylated region is comprisedof a largenumberof tandemrepeats of
amino acid sequences in which up to >60% are serine, threonine and
proline (STP repeats). Second type of the protein regions is located at
the amino- and carboxy- terminals, and sometimes interspersed
between the STP-repeats. The amino acid composition of these
regions is more consistent with a structure of globular proteins in
which there is a relatively little number of O-glycosylation and a
few N-glycosylation sites and a high proportion of cysteine (>10%).
The formation of S-S disulphide bonds between cysteines in these
cysteine-rich domains leads to a subsequent polymerization of
mucin dimers to form multimers (Fig. 1) [33].
Drug delivery systems that are used for mucosal delivery should
(i) have mucoadhesive properties, namely the ability to be bonded
and retained on the mucous surface for a long time, mainly
through interaction with mucin, (ii) ensure prolonged release of
BAS, and then (3) be detached of the mucosa causing minimal
damage to it [27,37,38]. Mucoadhesive properties of drug delivery
systems should also increase the bioavailability of the BASs
included in them [27]. Mucoadhesive drug delivery systems aredesigned for both local delivery and for systemic administration
via BAS penetration through mucous surfaces and entering the
blood circulatory system.
All new mucoadhesive delivery systems are to be pre-examined
and tested. At present, an impressive arsenal of various biological
(including tests on model animals) as well as physical and chemical
methods are in use for analysis of mucoadhesive properties, both
polymers and delivery systems based on nano- or micro-particles
[38]. The majority of these methods is based on the use of specific,
complex and expensive equipment. Methods of analysis using
mucous surfaces arewidely applied [37]. However,mucous surfaces
isolated from living organisms are characterized by fragility, hetero-
geneity, limited shelf life (2–3 h) and changeof thepropertiesduring
freezing that result in reduced reproducibility in experiments.
Meanwhile, mucoadhesive properties of different nano- and
micro-particles can be analyzed via adsorption of commercial
mucins [39]. This adsorption method is relatively simple, although
it is mentioned in a number of works that the results of the analysis
can be influenced by the method of isolation and purification of
mucin [34,40]. The decrease of mucin concentration in solution
can easily be determined by conventional methods of glycoprotein
detection [34]. It was shown that themethod of adsorption is highly
reproducible and is correlates well with other methods that are
based on the use of mucous surfaces [39]. Therefore the method
is recommended for the screening analysis of mucoadhesive prop-
erties for micro- and nano-particles of a different nature and com-
position, e.g. made of chitosan [41] or polyelectrolytes [42].
The loading of commercial mucin derived from the pig stomach
(in the concentration of 1 mg mL1) into vaterite microcrystals dur-
ing the crystal formation (co-precipitation) and via adsorption on
preformed crystals has been studied in our previous work [43].
The loading of mucin was higher for the co-precipitation compared
to the adsorption. At the same time, the change in the surface
charge of the particles for the co-precipitation was found to be less
than that for the adsorption method. The co-precipitation of mucin
has been recommended for BAS inclusion into the vaterite crystals;
this process mainly corresponds to the biomineralization on
mucous surfaces [44]. In the past decades, layer-by-layer (LbL)
assembly of biomacromolecules of various nature has been shown
as versatile tool allowing fine control over the biomaterials’ struc-
ture for biomedical and biomimetic applications [45–47]. The abil-
ity to employ mucin as a polyanion in sequential LbL adsorption of
molecules on vaterite microcrystals has been demonstrated that is
in a good agreement with results reported on mucin adsorption on
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soluble polymers [51]. However, adsorption of mucin on vaterite
microcrystals at concentrations of mucin relevant to actual concen-
trations in themucus has not been studied yet. In addition, an effect
of adsorption conditions and mucin properties is also not reported.
This work continues our recent study [43] and aims to investi-
gate how does the adsorption of mucin on vaterite microcrystals
depend on environmental conditions, i.e. (pH, ionic strength, the
presence of organic solvents and detergents), adsorption time and
glycoprotein concentration. This will allow to predict the mucoad-
hesive properties of vaterite microcrystals and crystal behavior in
mucosal environment. In addition, herein we continue the develop-
ment of approaches to stabilize microcrystals loaded with mucin
via the LbL deposition of polyelectrolytes which has been reported
recently [43] and is highly promising for the development of test
systems based on vaterite for studying the mucoadhesiveness of
various objects such as polymers, particles and microorganisms.
2. Experimental section
2.1. Materials
Calcium chloride anhydrous,93.0% (C1016), sodium carbonate
Na2CO3 anhydrous, 99.0% (S7795), commercial mucin from por-
cine stomach, Type III, (m1778), bound sialic acid 0.5–1.5%, pro-
tamine from salmon, fluorescein isothiocyanate isomer 1 (FITC),
2,4,6-trinitrobenzenesulfonic acid (TNBS), N-acetylneuraminic acid
from E. coli, ethylenediaminetetraacetic acid (EDTA), gel filtration
molecular weight markers kit MW 12–200 kDa (Sigma-Aldrich);
5,50-dithiobis(2-nitrobenzoic acid) (DTNB) (Serva, Germany); cys-
teine, >99.5% (BioUltra); Sephadex G-200 (Pharmacia) were used.
All chemicals used for the preparation of buffer solutions were lab-
oratory grade and purchased from Sigma–Aldrich. Before use,
mucin solutions were sonicated for 30–90 min using the ultrasonic
bath (Elmasonic S15H, Germany).
2.2. Analytical determination of mucin
The concentration of the glycoprotein mucin in solutions was
determined spectrophotometrically at the wavelengths of 214 nm
and 260 nm [52] or employing analytical size exclusion chromatog-
raphy using the column Biofox 17 SEC 8  300 mm (Bio-Works,
Sweden) in 0.15 M NaCl (the chromatographic system Smartline
(Knauer, Germany) [43]. Preliminary, bothmethodswere calibrated
using solutions of purified mucin with different concentrations in
the ranges 0.01–0.1 or 0.01–1 mg mL1. The column was addition-
ally calibrated using model proteins with different molecular
weights.
2.3. Purification of mucin via chromatography
15–45 mL of the mucin solution (5 mg mL1) was subjected to
the column filled with Sephadex G-200 (dimension 2.5  35 cm)
using the chromatographic system Bio-Logic LP (Bio-Rad, USA) in
the solution of ammonia (pH 9.0) with the elution rate of
0.5 mL min1 and collection time for one fraction of eluted solution
of 12 min. Absorbance was determined in the obtained fractions at
the wavelengths of 214, 260, and 480 nm. The fractions containing
mucin, as identified by absorbance and specific determination by
the Schiff’s method, were combined and freeze-dried as described
in [43].
2.4. Synthesis of Mucin-FITC
Commercially available mucin (4.5 mg mL1) has been labelled
as described in [43] using 1 mg mL1 FITC (dissolved in dimethyl-formamide) and carrying out the reaction in 0.5 M carbonate buffer
with pH 9.0 for 24 h at 4 C. The solution was exposed to chro-
matography analysis and the molar modification degree of the free
amino groups in mucin-FITC was found to be 17 ± 2% relative to
purified mucin [43].
2.5. Synthesis of desialated mucin
Commercially available mucin (0.3 mg mL1) has been
exposed to the solution of 0.01 M HCl and incubated for 3 h at
80 C. The solution was exposed to chromatography analysis
using the column filled with Sephadex G-200, as described above.
The content of sialic acids was found to be 2.30 ± 0.10 and
0.41 ± 0.05% for initial mucin and desialated mucin, respectively,
as reported in [43].
2.6. Mucin loading into the CaCO3 crystals by adsorption
The CaCO3 crystals were formed according to the standard pro-
cedure [19] by adding of the solution of CaCl2 to the equimolar
solution of Na2CO3. The crystals were washed twice with water
and dried in the oven at 70 C. The aqueous suspension of CaCO3
crystals (20 mg mL1) was agitated with 1–6 mg mL1 mucin solu-
tion on a shaker for 30 min. The precipitate was separated by cen-
trifugation (2 min, 1000 g) followed by removal of the supernatant
and double washing with water. The content of mucin was deter-
mined in the supernatant and the washing solutions.
The amount of the loaded protein at equilibrium was calculated
using the following equation:
qe ¼
ðc0  ceÞ  V
m
where qe – the adsorption capacity (mg g1), c0 and ce – the initial
and equilibrium mucin concentrations, respectively (mg mL1); V
is the volume (mL) of the mucin solution; and m is the mass of
CaCO3 (g).
2.7. Kinetics of mucin adsorption
The kinetics of mucin adsorption was monitored with respect to
the loss of mucin in solution by absorbance at 260 nm or with
respect to the accumulation of fluorescence signal in vaterite
microcrystals in the presence of mucin-FITC as analysed by fluores-
cence microscopy (EVOS FL, Thermo Fisher Scientific, USA).
For the latest case, the kinetics of mucin loading has separately
been assessed for microcrystal interior and its surface. The back-
ground fluorescence has been subtracted from the mean fluores-
cence signal. The photo-bleaching effect during the experiment
was found to be insignificant (data not shown) and has been
neglected. At least 10 vaterite microcrystals have been analysed
for each time point to get an average fluorescence signal.
2.8. Mathematical fitting
Experimental points for kinetics of mucin adsorption (up to 6 h
of mucin loading) has been fitted with the three models [53]
described below:
1. Pore diffusion model (Bangham’s equation):
Among a number of diffusional models, Bangham model has
been chosen because the porosity seems to be the most apparent
property of the vaterite CaCO3 microcrystals. Bangham equation
was applied in the following form:
lnqt ¼ a ln t þ lnK
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Adsorption kinetics that is described by the pseudo-first order
reaction model with the rate constant k obeys the following
equation:
lnðqe  qtÞ ¼ kt þ lnqeFig. 2. The scheme of the preparation of mucin-containing microparticles: I –
vaterite microcrystals; IIa and IIb – microcrystals coated with one and multiple
mucin layers, respectively; IIIa – microcrystals sequentially coated with oppositely
charged layers of protamine and mucin; IIIb – (PRO/MUC)3 microcapsules obtained
after elimination of CaCO3 from the coated crystals using EDTA. . Adopted from [43]3. Pseudo-second order model:
This model is described by the linear equation:
1
qt
¼ 1
qe
þ ð 1
kq2e
Þ  1
t
Maximum adsorption capacity has been fixed (35 mg g1)
based on the experimental data. The goodness of the fit was
assessed based on R-squared coefficient calculated as
1
P
ðyif iÞ2P
ðyiyav Þ2
, where fi is the predicted value from the fit, yav is
the mean of the observed data, yi is the observed data value.
2.9. LbL deposition of mucin
The LbL deposition of either mucin (control experiment) or
mucin and protamine (a pair of polymers used) has been performed
on the synthetized vaterite CaCO3 crystals. In either case, the poly-
mer concentration was 0.5 mg mL1 and the crystals concentration
was 20 mg mL1. The coated crystalswerewashed twicewithwater
and their f-potential was measured after each adsorption step. The
CaCO3 crystals coated with three (mucin-protamine) bilayers were
dissolved by dropwise addition of equimolar amount of 0.2 M EDTA
(to solubilize all the crystals), and then the formed polyelectrolyte
microcapsules were washed three times with water by centrifuga-
tion. The content of mucin in the microcapsules was determined
by determination of mucin content in washing solutions obtained
during the capsule preparation procedure.
2.10. Characterization of the crystals and capsules
Analysis of microparticles prepared in this study (CaCO3 crys-
tals and polyelectrolyte capsules) was carried out using light opti-
cal microscopy (Carl Zeiss JENA, Germany) and scanning electron
microscopy (SEM, Zeiss DSM 40, Germany). The size of the
nanocrystallines (the CaCO3 crystals are made of) was determined
from particle surface analysis in SEM photographs, as described in
[10]. Determination of hydrodynamic diameter of commercial
mucin (0.1 mg mL1) was carried out using dynamic light scatter-
ing (DLS, Malvern Zetasizer Nano ZS, UK). A suspension of
microparticles (0.5 mg mL1), solutions of 0.1 mg mL1 mucin or
protamine were used DLS. Electrophoretic mobility of mucin, pro-
tamine and vaterite microcrystals (pure or coated with mucin/pro-
tamine layers) was measured under the same conditions using
Malvern Zetasizer Nano ZS, UK. f-potentials have been calculated
using the Smoluchowski equation.
3. Results and discussion
3.1. Physical-Chemical properties of vaterite microcrystals coated with
mucin
Vaterite microcrystals were obtained by mixing equimolar
solutions of CaCl2 and Na2CO3 (Fig. 2, No. 1). According to SEM
images (Fig. 3a), the dried crystals used in this study had spherical
shape with an average diameter of 3.3 ± 0.8 lm. The average
diameter of nanocrystallines in the crystal was 109 ± 25 nm thatcorroborates well with literature data [10]. The pore size in the
microcrystals prepared by similar procedure has previously been
determined by Brunauer-Emmett-Teller adsorption/desorption
method and was found to be in the range 5–40 nm [19]. The sur-
face charge of the crystals dispersed in water appeared to be
9 ± 1 mV as measured by DLS.
The commercial mucin from the pig’s stomach (further - mucin)
was used in this study. Mucin had a surface charge of 15 ± 2 mV
according to DLS in the solution of 1 mg mL1 (Fig. S1) and was
represented by two fractions with hydrodynamic diameters in
the range 30–50 and 200–300 nm, respectively (Fig. S2). Purified,
FITC-labelled and desialated mucins were prepared from commer-
cial mucin and gel filtrated. These mucins contained only a short
fraction with a hydrodynamic diameter in the range 30–50 nm
because the heavy fraction has been filtered off.
SEM imaging of the microcrystals loaded with mucin did not
reveal any significant changes in the morphology of the vaterite
crystals (Fig. 3b): microsphere diameter 3.6 ± 1.1 lm, nanocrystal-
lite size 80 ± 18 nm. According to results of the light microscopy
analysis, mucin-coated vaterite microcrystals have been found to
be present in less aggregated state in water suspension. In addi-
tion, they are significantly less prone to recrystallization into more
stable calcite polymorph during storage in water compared to
uncoated vaterite microcrystals. According to the DLS results, the
adsorption of mucin on vaterite microcrystals resulted in a slight
change of zeta-potential to the negative value of 15 ± 3 mV,
which indicates the binding of mucin to the crystal surface. This
is in a good agreement with the results presented in our previous
work [43] that compares two methods of mucin adsorption into
vaterite crystal: pre-loading (conventionally called co-synthesis)
and post-loading (adsorption) of mucin. Herein, we focused on
mucin post-loading (Fig. 2, No. II) that has been studied under
the constant concentration (20 mg mL1) of vaterite microcrystals,
while the loading time, medium and mucin concentration (II-a) as
well as a number of deposition steps for mucin multiple adsorption
(II-b) have been varied.
Fig. 3. SEM images of vaterite microcrystals before (a) and after (b) mucin adsorption.
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Kinetical analysis of mucin adsorption (Fig. 4) has revealed that
the amount of mucin adsorbed on the vaterite microcrystals shar-
ply increased in the first 10 min followed by the gradual down for
the next 5 h and then consequently reached the plateau.
The process of adsorption into porous matrices is usually con-
sidered as three sequential steps of (i) mass transfer from the bulk
to the solid surface followed by (ii) surface adsorption and (iii) dif-
fusion of the adsorbate into the adsorbent interior. Typically, diffu-
sion in the bulk is not considered as a rate-limiting step because of
typically applied elimination of diffusional limitations by mechan-
ical stirring of the solution. Some models of adsorption kinetics
assume that the sorption is the rate-limiting step, while for other
models it is supposed that the diffusion is the rate-limiting step.
Mathematical fitting to the models allows the prediction of the
adsorption mechanism.
In this study, we applied three well-known models, namely
pore diffusional model proposed by Bangham and two commonly
used adsorption models of pseudo-first (PFO) and pseudo-second
order (PSO) (Fig. 4 and Table S1) [53]. All of them are applicable
for homogeneous adsorption of mucin on spherical particles from
solutions with the concentration of mucin far away from satura-
tion (belowmucin solubility). The best fitting to the Banhammodel
(R2 0.999 vs. 0.769 and 0.106 for PSO and PFO, respectively) indi-
cates that the diffusion of mucin inside vaterite CaCO3 microcrys-
tals through the pores is the slowest and thus the rate-limiting
step in mucin adsorption.
In order to put more evidence on adsorption mechanism and
understand the distribution of glycoprotein in vaterite microcrys-Fig. 4. Kinetics of mucin adsorption on vaterite microcrystals (initial concentration
of mucin is 1 mg mL1). Cumulative amount of mucin adsorbed on CaCO3 crystals
(qe) was determined by the absorbance at 260 nm. Black rhombs – experimental
points, mathematical fitting with three models is shown by solid and interrupted
lines.tals, the kinetics of adsorption of mucin-FITC was also studied by
means of fluorescence microscopy (Fig. 5). Immediately after expo-
sure of vaterite crystals into mucin-FITC solution, the glycoprotein
was mainly located on the surface of the crystals (Fig. 5a–c). This
was followed by further accumulation of more mucin-FITC on the
crystal surface and partial permeation of mucin-FITC inside the
microcrystals during the next 30 min of incubation (Fig. 5d–f).
The kinetics of accumulation of fluorescence signal on the crystal
surface and inside the crystals has been investigated (Fig. 5g) show-
ing that the adsorption on the surface of the crystals occurs faster
compared to the accumulation of mucin-FITC in the crystal interior.
Altogether, these results allow to propose that the rate of mucin
adsorption is determined by diffusion of mucin into the pores of
the vaterite microcrystals rather than its adsorption on the crystal
surface.
3.3. Influence of mucin concentration on adsorption capacity of the
microcrystals
It is known that mucin concentration determines its aggrega-
tion and gelling properties [33]. This motivated us to investigate
the influence of the concentration of commercial mucin in the
range of 1–6 mg mL1 on its adsorption to the vaterite microcrys-
tals (Fig. 6a). The upper value of the tested concentration of mucin
was chosen to be similar to the concentration of mucin in the
mucus of the gastrointestinal tract [34]. Based on these data, an
isotherm of mucin adsorption was constructed (Fig. 6b) and ana-
lyzed on the basis of the assumptions of Langmuir monolayer
adsorption according to the classical equation below:
qe ¼
qmaxKace
1þ Kace
where qe – equilibrium adsorption capacity (mg g1); ce – concen-
tration of mucin in the solution at equilibrium (mg mL1);
qmax – maximum adsorption capacity (mg g1); Ka – adsorption
equilibrium constant (mL mg1).
Adsorption isotherm was further plotted in linear coordinates
1/qe = f (1/ce). Maximum adsorption capacity qmax of 159 ± 9 mg g1
and the adsorption equilibrium constant Ka = 2.52 mL mg1 were
calculated with the coefficient of determination R2 of 0.994. The
qmax obtained is 4.6 times higher and the Ka is 3.6 times lower than
those values determined for adsorption of high-molecular-weight
enzyme catalase (250 kDa, pI 5.4) to the crystals. The enzyme has
a similar sign of a charge under the adsorption conditions but a
smaller diameter of 10 nm [11].
In addition, the Gibbs free energy of the adsorption process was
calculated as follows:
DG ¼ RT  lnKa
Fig. 5. Fluorescence (a,d) and optical transmittance (b,e) images of CaCO3 crystals after 1 and 30 min of incubation in mucin-FITC solution, respectively. Fluorescent profiles
(c,f) are taken along the white lines in the images (a) and (d) showing the distribution of mucin-FITC inside CaCO3 crystals after 1 and 30 min incubation, respectively. Scale
bars are 10 mm. (g) kinetics of mucin-FITC adsorption on the surface of CaCO3 microcrystals (white squares) and kinetics of penetration of mucin-FITC inside vaterite crystals
(black circles).
Fig. 6. Mucin adsorption capacity on vaterite microcrystals as a function of initial
(a) and equilibrium (b) concentration of the glycoprotein. qe was determined after
30 min of incubation by measurements of the absorbance at 260 nm.
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temperature (K); Ka is the constant of adsorption equilibrium
(L mol1).
The Gibbs energy of the mucin adsorption process was found to
be 35 ± 4 kJ mol1 and was in a good agreement with the value
for catalase and a number of other previously studied proteins
[11]. Negative value of Gibbs free energy for mucin adsorption
indicates a significant shift in the equilibrium towards adsorption.
This in turn gives a high content of mucin in the crystals: at a max-
imum adsorption capacity, mucin content can reach a value of up
to 16% by the mass of the vaterite crystals.
Interestingly, some less abundant mucus proteins (e.g., lyso-
zyme) have lower adsorption capacity for vaterite crystals com-pared with mucin (about 15 mg g1 for lysozyme post-loading in
CaCO3 [54]). The same is also valid for serum albumin (ca
20 mg g1) [54]. This extremely high affinity of CaCO3 crystals to
mucin might open prospects for the use of vaterite crystals for
selective mucosal delivery in future.
3.4. The role of mucin purification and desialization
In addition, the adsorption capacities of commercial, purified and
desialated mucins (prepared by analytical chromatography) on
vaterite microcrystals were studied and compared. Purified mucin
has the largest negative surface charge of 27 ± 1 mV and its
adsorbed mass on microcrystals was by 25 ± 3% more than that for
commercial mucin. This can be explained by higher capacity of the
crystals for smaller mucin molecules as they can permeate into the
pores of the crystals where more surface is available for adsorption.
The desialatedmucin (degree of desialization 80%)was adsorbed on
microcrystals giving by 1.5 times less adsorbed amount than that for
commercialmucin. The difference in the adsorption ofmucin prepa-
rations evidences an important role of sialic acids and, consequently,
a role of electrostatic interactionsduring theadsorptionof theglyco-
protein. Consequently, an increase in the content of sialic acids in
mucin can lead to strengthening the binding ofmucin bymicrocrys-
tals. We believe this is an important finding for future study on
mucin adsorption, as in the case of cancer diseases, the content of
sialic acids inmucins increases [55]. Taking into account that CaCO3
crystals have been recently proposed as anticancer delivery carriers
[5,56], the elevated levels of sialic acid in mucosal cancer might
enhance the uptake of vaterite-baseddelivery systemsby themucus
surrounding cancer cells.
3.5. The influence of adsorption medium
The charge, conformational and aggregative states as well as
rheological properties of mucin significantly depend on its envi-
ronmental conditions [57–60]. This stimulated us to investigate
the adsorption of mucin on vaterite microcrystals exposed into
medium with different pH (5  103 M TRIS buffer solution, pH 7–
9), ionic strength (the presence of 0.15–1.0 M NaCl at pH 7.1)
and in the presence of organic solvent (20% isopropanol) of surfac-
tant (0.0035 M SDS). The cumulative amount of bound mucin has
been compared with the control value for glycoprotein adsorption
from water solution (Fig. 7). One can expect a contribution of elec-
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the crystals. Below the experimental results are discussed in a view
of the expected interactions.
The amount of mucin adsorbed to the microcrystals slightly
increased with increasing pH from 7 to 9. This can be explained
by the stable negative charge of mucin in the studied pH range that
is much above the pI of mucin, i.e. 3–4 [33] and rather low charge
of the vaterite microspheres [4]. Thus, variation of pH in this range
does not significantly affect the adsorption process as variations of
electrostatic interactions are not expected. The addition of NaCl up
to physiological values (0.15 M) resulted in the slight increase of
adsorption capacity. This phenomenon can be explained by a
decrease in the electrostatic repulsion between the glycoprotein
molecules in the presence of salt (charge screening), which agrees
well with the results of [57]. Reduced repulsive interactions
between mucin molecules can allow more mucin molecules to be
loaded into the pores of the crystals. Herein, it seems that at low
NaCl concentrations the strengthening of mucin-mucin interaction
dominates over the diminution of mucin-CaCO3 attraction. With
further increase of the salt concentration up to 1 M, the amount
of bound mucin gradually decreases that may be due to significant
screening of charges at high salt concentration that can weaken on
electrostatic attraction of mucin to CaCO3 resulting in less amount
of the adsorbed mucin. In this way, the abolishment of mucin-
CaCO3 attraction dominates over increasing intermolecular mucin
interactions. At the same time substantial amount of adsorbed
mucin even at very high ionic strength (1 M NaCl) points on the
presence of non-Coulombic interactions between mucin and the
crystals and/or intermolecular mucin interactions. This can most
probably be attributed to hydrophobic interactions that can take
place between mucin molecules.
The presence of 20% isopropanol did not alter the amount of
mucin adsorbed as compared with the adsorption from aqueous
medium,whichalso supports a significantor evenadominatingcon-
tribution of hydrophobic interactions into the mucin binding to the
crystals. Otherwise an effect of solvent polarity should be
pronounced.
The presence of 0.0035 M sodium dodecyl sulfate results in
significant drop (ca 57%) in the amount of adsorbed mucin. One
can explain this by removal of mucin molecules from pores of
the crystals due to strong binding to SDS and mucin in solution
as driven by hydrophobic interactions. This assumption is in a
line with the crucial role of hydrophobic interactions as described
above.Fig. 7. The influence of the composition of the medium on the equilibrium adsorpti
microcrystals. Adsorption capacities are determined by absorbance at 260 nm after the
mucin is 1 mg mL1, 20 mg mL1 of vaterite crystals are used in all the experiments.Concluding from the above, the adsorption of mucin, and, con-
sequently, the mucoadhesive properties of the vaterite microcrys-
tals, can considerable be varied depending on the environmental
conditions.
3.6. Stepwise mucin adsorption
The effect of stepwise LbL adsorption of mucin on the vaterite
microcrystals (Fig. 2-IIb) was considered. This differs from our pre-
vious studies [43], where the mucin was loaded into the crystals by
co-precipitation. At each of the six adsorption steps, vaterite micro-
crystals (20 mg mL1) were consequently incubated in 0.5 mg mL1
mucin solution, centrifuged and washed with water (Fig. 8). An
increase in the number of adsorption steps is accompanied by a
decrease in the stepwise binding of mucin and simultaneous
increase in the total adsorption of mucin by the crystals. At the
same time, an increase in the number of adsorption steps did not
cause the changes in the charge of microcrystals, which varied in
the range from 12 to 15 mV. This phenomenon can occur due
to redistribution of mucin on the surface of crystals or possible
additional binding between the layers of mucin due to the forma-
tion of intermolecular disulfide, hydrogen bonds and hydrophobic
interactions. Our further studies using Elman’s method [61] helped
to reveal the absence of free SH groups in mucin meaning that the
formation of additional disulfide bonds should not occur. Thus,
hydrogen bonding and hydrophobic interactions between mucin
molecules seem to play a vital role in adsorption of mucin resulting
in formation of multiple mucin layers. Similar explanation has been
proposed for the stepwise adsorption of mucin on vaterite crystals
pre-loaded with mucin [43].
The microcrystals coated with six layers of mucin (Fig. S3) were
treated with EDTA to dissolve solid CaCO3 that led to spontaneous
disintegration of the particles (Fig. 2, No. II). The same behavior
has been reported for twice less number of adsorbed layers [43]
which indicates that mucin multilayers cannot be stabilized solely
by hydrogen bonding and hydrophobic interactions. Such a lowper-
formance of mucin retention into vaterite microcrystals can be
improved by employing the LbL adsorption of the glycoprotein in a
pairwith apolycation. These results are shownanddiscussedbelow.
3.7. The LbL mucin/protamine adsorption on vaterite microcrystals
The retention of adsorbedmucin on vateritemicrocrystals for the
LbLdepositionofmucinandanoppositely chargedpolycation (Fig. 3,on capacity (qe) of vateriate crystals for commercial mucin (mg g1) on vaterite
incubation in the medium (5 mM TRIS buffer) during 1 h. Initial concentration of
Fig. 8. Stepwise multiple mucin adsorption on vaterite microcrystals. Adsorption
capacities are determined by the measuring an absorbance of supernatants at
260 nm.
Fig. 9. (a) The amount of mucin adsorbed on vaterite microcrystals during
sequential deposition of (mucin/protamine)3 and (protamine/mucin)3 coatings.
The steps of mucin adsorption are shown with filled markers; adsorption of
protamine corresponds to non-filled markers. Adsorption capacities are determined
by measuring mucin absorbance in supernatants at 260 nm. (b) The change of zeta-
potential of the microcrystals during sequential deposition of (mucin/protamine)3
coating. Initial concentrations of mucin and protamine are 0.5 and 1.0 mg mL1 for
each deposition step, respectively.
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11, zeta potential in water solution + 7 mV) that is actively used as a
model biologically relevant polyelectrolyte [62] has been chosen.
In continuation of our recent study [43] where the stability of
(mucin-protamine)3 capsules have been proven by optical micro-
scopy, the LbL adsorption of protamine andmucin was investigated
for either protamine ormucin used as a first deposition layer (Fig. 9).
After each adsorption step, the microcrystals were washed twice to
remove unbound polyelectrolyte. Fig. 9a shows the dependence of
the amount of mucin loaded into microcrystals from a deposition
step, whichwas determined bymeasuring the glycoprotein concen-
tration in the supernatant and washing solutions and is referred to
themass of the initial CaCO3. The amount of boundmucin increased
during the adsorption of mucin and slightly decreased during the
following adsorption of protamine, indicating replacement of some
amount of mucin during deposition of the polycation. This is in a
good agreement with the data obtained for LbL deposition of mucin
with other polycations such as polyallylamine hydrochloride [63],
chitosan [64] and lactoperoxidase [48,65].
Interestingly, as can be concluded from the Fig. 9a, the amount of
bound mucin almost did not depend on the sequence of the poly-
electrolyte deposition steps (defined by the first layer). This phe-
nomenon can be explained by low adsorption of protamine onto
vaterite microcrystals as a first layer, which was demonstrated ear-
lier in our work in which the polypeptide was almost completely
eluted from crystals during washing (qm 2.6 ± 0.1 mg g1) [11]. At
the same time the observed phenomenon can be explained by a sig-
nificant role of intermolecular interactions between mucin mole-
cules as discussed above. This would reduce an impact of
electrostatic interactions to complexation of mucin and protamine.
Both factors described above may be responsible for no effect of a
sequence of polymers deposited on the absolute amount of
adsorbed mucin as a function of a number of layers.
The adsorption of polyelectrolytes led to the recharging of the
surface of microcrystals from negative values for mucin deposition
steps to positive values for protamine deposition, which confirms
the formation of a polyelectrolyte complex between mucin and
protamine (Fig. 9b) and indicate electrostatic attraction between
polymers. However, the values of zeta-potential are rather low
(absolute values do not exceed 15 mV) indicating low charge den-
sity on the surface of the polymer-coated crystals.
Vaterite microcrystals coated with three polyelectrolyte bilay-
ers, regardless of the polyelectrolyte application sequence used,
were stable during storage in water at 4 C without recrystalliza-
tion into calcite for 3 months. This shows a strong stabilization
effect. Typically bare crystals are recrystallized in water upon over-
night storage. More stable non-porous calcite polymorph is formed
from less thermodynamically stable vaterite. Here the coatingstops the recrystallization most probably by suppression of ion dif-
fusion from the crystal surface since this solution-mediated pro-
cess is supposed to be responsible for the recrystallization. Such
strong stabilization can be utilized in future for preparation of
mucoadhesive carriers with long term BAS delivery options.
The dissolution of (mucin/protamine)3 coated CaCO3 crystals
with 0.2 M solution of EDTA resulted in the formation of polymer
microcapsules (Fig. 2, IIIb). This confirms the stabilization of poly-
electrolyte layers by electrostatic interactions, because the crystals
coatedwith onlymucin layers completely dissolved in the presence
of EDTA. Most probably the hydrophobic interactions between
mucinmolecules are strong but their strength is not enough to keep
one-component mucin capsules intact. High flux of ions during the
crystal dissolution may affect stability of polymer coating and
stable coating can resist the high osmotic shock only if multiple
cooperative interactions (both electrostatics and hydrophobic
interaction) are involved. It should be noted that simplistic hollow
structure of the capsules shown in Fig. 2 (IIIb) can differ from actual
structure of the capsules that might appear as matrix-type capsules
due to possible presence of mucin inside the capsule lumen. Inter-
nal structure of the capsules requires further clarification.4. Conclusion
The adsorption of mucin on mesoporous vaterite microcrystals
has been investigated. The loading of mucin does not affect the
structure of vaterite crystals. The study of adsorption kinetics
demonstrated a rapid loading of mucin at initial time of adsorption
followed by slow adsorption step for ca 5 h. Bangham adsorption
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pseudo-second order models. This adsorption kinetics has been
explained from the view of pore diffusional model meaning that
the diffusion of mucin inside vaterite crystals is supposed to be a
rate-determine step. This conclusion was also supported by direct
observation by fluorescence microscopy focusing on mucin local-
ization into the crystals.
Analysis of mucin adsorption at varied pH, ionic strength, and
polarity of a solvent allow to suggest a contribution of both electro-
statics and hydrophobic interaction into the mucin-crystal binding.
This is also supported by observation of layer-by-layer deposition of
mucin and protamine onto the crystals as well as stability observa-
tions for multilayer one-component mucin/mucin and two-
component mucin/protamine capsules. There is no effect of a depo-
sition sequence for the layer-by-layer deposition of mucin and pro-
tamine that may be due to significant impact of intermolecular
mucin-mucin hydrophobic interactions. However, despite this, pure
mucin/mucin capsules are not stable compared to well-defined
mucin/protamine ones indicating an impact of electrostatics. Elec-
trostatic interactions are also revealed by zeta-potential measure-
ments for mucin/protamine coating and by study on adsorption of
desialated mucin onto the crystals. Mucin adsorption studied here
is characterized by thermodynamic parameters such as the Gibbs
free energy (35 ± 4 kJ mol1) and equilibrium constant (Ka = 2.52 -
mL mg1). Those parameters are well in a line with results obtained
for adsorption of a number of model proteins indicating similar
behavior of the glycoprotein mucin compared to pure proteins.
The results obtained on the influence of environmental condi-
tions on mucin adsorption lead to the conclusion that vaterite
microcrystals can adsorb substantial amount of mucin (ca. 16%
by mass), and, consequently, bind to mucus, i.e. possess mucoad-
hesive properties. It is possible to make an assumption about the
retention of microcrystals by a mucus surface and the prospects
for their use for mucosal drug delivery. High adsorption of mucin
on vaterite microcrystals seems to be promising finding for the
use of this glycoprotein as a polyanion for layer-by-layer polyelec-
trolyte adsorption and, subsequently, preparation of polyelec-
trolyte microcapsules. Stabilization of vaterite crystals by mucin
adsorption and the production of mucin-containing microcapsules
is considered as an interesting and promising approach for the
development of the test-systems for the purpose of studying the
mucoadhesive properties of various objects, for example, polymers
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